Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BST2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC283352 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DKK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHE41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RORA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LETM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01234 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AJAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APRT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC42EP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPPED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on